I am grateful to the Chair of the Select Committee for that. We have had this discussion before and I have to disappoint him slightly, in the sense that of course the EU is moving as well on this. I suspect we will probably end up in a similar place at a similar time. However, he is absolutely right to point out the potential advantages.
The amendments before us are all Government amendments, because, despite the excellent learned and erudite arguments put by my colleagues in the other place—I pay tribute to Baroness Hayman, Baroness Jones and Lords Winston, Krebs, Trees and Cameron, among others—not much has changed, and that is genuinely disappointing. However, some improvements have been made. A number of the amendments move regulations to the affirmative procedure, as the Minister explained, and that allows some, if limited, further scrutiny, which is welcome. Amendment 1 to clause 1 is the Government’s further attempt to codify a particular knotty problem that we discussed at length in Committee. So the Minister will be pleased to know that we will not be opposing their amendments tonight. We will merely pointing be out how much more improved the Bill could have been had they had the confidence to embrace our positive suggestions.
I say that not least, Mr Deputy Speaker, because if you had the chance to peruse the Sunday newspapers, as I hope you had the time to do and enjoy, you would have seen comment on today’s gathering of international experts on human gene editing. Although the techniques
such as CRISPR-Cas9 may be similar, this is of course a different issue from those under consideration today. However, I would argue that many of the ethical issues around animals are not dissimilar. That is why the Government’s refusal to adopt our suggestion of an overseeing authority to look at these very complicated and challenging issues is so disappointing. We have a great chance to be genuinely world-leading in this area. We have brilliant people such as those at the Nuffield Council on Bioethics, yet the Government are, apparently, not interested. That is a wasted opportunity.
Let us look at these amendments in more detail. As I have said, on a number of issues the Government have bowed to informed argument in the other place and agreed that regulations should be subject to the affirmative procedure: on the release or marketing of genetically edited organisms; on information that must be included in the register; on the animal welfare declaration that has to be made; and on the body to be designated as the animal welfare advisory body. That is all welcome. But one of the most powerful and consistent criticisms has been the vagueness of the Bill on many issues and the lack of detail, particularly relating to the proposals regarding animals and when regulations might take effect. I am afraid that these amendments do not seem to help us on this, and I would be grateful if the Minister could comment on it. The promise at the outset was that nothing would be done on animals until the science was further advanced; it has been described as a “step-by-step approach”. Will the Minister reconfirm that commitment today and tell us what timeframe is actually envisaged? As for companion animals or primates, can he give any reassurances on that today? Many people will be keen to hear what he has to say on it.
As I have already indicated, the most significant amendment is to clause 1, as the Government seek once again to explain what they consider to be a natural process. We had an interesting and extensive discussion in Committee on this point, both with those giving evidence and between members, and it was discussed at length in the other place. I fear that the Government have struggled with this, and I am not sure the new wording takes us much further forward. In general, the Government have sought to define a new category, “precision breeding” which many expert witnesses doubt has much meaning. The particular concern is whether the definitions accurately describe gene editing, without allowing gene modification in through the back door, with one of the key issues being whether exogenous material is included.
The amendment before us introduces yet another term—modern biotechnology. This is also ill-defined, and, as argued by Lord Krebs in the other place, may not stand the test of time, or, more importantly, as we heard in expert evidence, legal scrutiny and challenge. I appreciate that this is difficult territory and hard to define, and almost any sentence fails to capture the complexity, but we were promised at the outset that GM is excluded, and it would be helpful to have the Minister confirm that clearly again today.
l am conscious that you do not want lengthy speeches, Mr Deputy Speaker, so let me conclude. The learned and lengthy discussions in the other place showed just how complicated this subject is. Sadly, the Government
have made only limited changes in the light of those discussions. Those changes are welcome, so we will not oppose them, but we think that this is a missed opportunity to set out the strong regulatory framework that would have reassured the public, and given investors the confidence that the sector needs.
There is significant opportunity for good here, but there are also risks—risks we may not fully understand. It is also worth bearing in mind that one mistake could tarnish the entire technology. As so often, the Government have gone for the short-term quick fix—the sticking plaster. How much better it would have been to have set up the robust long-term framework that could have established the UK as the setter of the standard that others will follow. That is unfinished business, and it is for another day.